Log in
NYSE:STE

Steris Stock Forecast, Price & News

$175.91
+4.40 (+2.57 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$171.25
Now: $175.91
$176.06
50-Day Range
$153.12
MA: $158.99
$171.51
52-Week Range
$105.69
Now: $175.91
$176.06
Volume1.05 million shs
Average Volume622,073 shs
Market Capitalization$14.96 billion
P/E Ratio36.57
Dividend Yield0.93%
Beta0.71
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$8.69 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Employees13,000
Market Cap$14.96 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$175.91
+4.40 (+2.57 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by Coronavirus (COVID-19)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, STE shares have increased by 21.1% and is now trading at $175.91.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris
.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris
.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) announced its quarterly earnings data on Monday, August, 3rd. The medical equipment provider reported $1.31 EPS for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.33. The medical equipment provider had revenue of $668.90 million for the quarter, compared to analysts' expectations of $643.38 million. Steris had a return on equity of 16.24% and a net margin of 13.69%. The company's revenue was down 4.0% on a year-over-year basis. During the same period last year, the firm posted $1.23 earnings per share.
View Steris' earnings history
.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, August 3rd. Investors of record on Thursday, August 27th will be given a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Wednesday, August 26th. This is an increase from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history
.

What price target have analysts set for STE?

4 equities research analysts have issued 12-month target prices for Steris' stock. Their forecasts range from $170.00 to $175.00. On average, they anticipate Steris' stock price to reach $172.50 in the next year. This suggests that the stock has a possible downside of 1.9%.
View analysts' price targets for Steris
.

Are investors shorting Steris?

Steris saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,140,000 shares, an increase of 24.0% from the August 15th total of 919,500 shares. Based on an average daily trading volume, of 459,000 shares, the days-to-cover ratio is currently 2.5 days.
View Steris' Short Interest
.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Home Depot (HD), Mcdonald's (MCD), Medtronic (MDT) and Cisco Systems (CSCO).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.18%), WCM Investment Management LLC (7.41%), William Blair Investment Management LLC (1.44%), ArrowMark Colorado Holdings LLC (1.36%), Bessemer Group Inc. (1.09%) and Bank of America Corp DE (1.04%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris
.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Goldman Sachs Group Inc., Vanguard Group Inc., Fisher Asset Management LLC, Assenagon Asset Management S.A., Nuveen Asset Management LLC, Two Sigma Advisers LP, and Robeco Institutional Asset Management B.V.. Company insiders that have sold Steris company stock in the last year include Cary L Majors, John Adam Zangerle, Mohsen Sohi, Richard C Breeden, and Richard Martin Steeves.
View insider buying and selling activity for Steris
.

Which institutional investors are buying Steris stock?

STE stock was acquired by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Great West Life Assurance Co. Can, FIL Ltd, TimesSquare Capital Management LLC, Retirement Systems of Alabama, Bank of America Corp DE, Principal Financial Group Inc., and Principal Financial Group Inc..
View insider buying and selling activity for Steris
.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $175.91.

How big of a company is Steris?

Steris has a market capitalization of $14.96 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.